Kevin A. Gaffney

Madrigal Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel treatments for liver, cardiovascular, and metabolic diseases.

· Selected as one of eight Regional Account Directors across the U.S. to play a pivotal role in introducing Madrigal, a start-up biopharmaceutical company, to the payer community and successfully launching Resmetirom, the first FDA-approved treatment for non-alcoholic steatohepatitis (NASH).

· Responsible for managing regional payer accounts (23 targeted) across the Northeast (New England + New York), spanning commercial, Medicaid, and Medicare channels.

· Key contributor to the market access team, achieving 80% commercial channel access within three quarters of launch while safeguarding gross-to-net margins for the organization:

o 86% commercial lives with established access/policies across targeted Northeast accounts within 6 months of launch.

o 93% state Medicaid lives with established access/policies at targeted Northeast Medicaid programs within 6 months of launch.

· Recognized as an "Operation Blue" winner for securing access with targeted Blue Cross Blue Shield plans within one quarter of launch.

· Selected by Executive Director to lead disease state education for regional account team

· Recognized by market access leadership for leveraging KOL expertise to drive access for Rezdiffra within Northeast payers.

One of two positions nationwide ensuring continuity and accountability for the U.S. Migraine franchise.

· Act as conduit between Brand, Field Access, US Market Access, and Field Sales to implement strategies focused on national payer accounts.

· Facilitate cross-functional collaboration to capitalize on account opportunities with immediate business impact.

· Provide payer access education and strategic direction to maximize pull-through at downstream regional levels.

• 1 of 4 Regional Account Directors in US responsible for management of 27 Regional/IDN accounts across 10 states
• Leadership without authority within 3 Regions & 14 Districts
• Empower field sales relative to market access while strengthening team collaboration to achieve goals
• Lead field sales in targeted pull-through initiatives of market leading migraine therapy based on access position with key payers
• Partner with National Account Directors to leverage & pull-through national payer access at downstream regional level

• Payer Accounts, Northeast, US Market Access, Member of Payer Access team that launched Incyte’s first drug into pharmacy benefit space
• 1 of 4 Regional Account Directors in US hired to launch Atopic Dermatitis drug to regional payers
• Covering New England, NY, NJ, and portion of Pennsylvania
• 26 Targeted Accounts in Northeast
• Provided guidance & education to internal stakeholders around working under the pharmacy benefit
• Northeast Payer landscape expert- first point of contact for field sales teams- “Lead from a distance”
• Led development/creation of Incyte’s very first Pull- Through initiative “road map” and SOP

• Expanded product portfolio access for Teva's specialty branded products via contract negotiations, execution of brand strategies and collaboration with Medical and Pharmacy Directors
• Prominent level of collaboration and communication with both internal and external stakeholders to ensure effective contracting discussions and clinical messaging
• Currently managing sixteen accounts which include regional payers, IDNs, ACOs, specialty pharmacy and provider networks in New England and upstate New York markets
• Launched ten specialty drugs (biologic, IV, injectable, device and orphan) as well as two biosimilars while working within both medical and pharmacy benefits
• Successfully negotiated direct portfolio contracts with market leading health plans and PBMs
• Negotiated reimbursement criteria for medical and pharmacy benefit drugs at all targeted payer accounts
• Developed contract proposals, including financial analytics and impact/profitability scenarios towards forecasting
• Created and executed multiple pull-through/push-through initiatives to leverage account access towards increasing product share & volume and in some instances, improve product access
• Commercial/Medicare/Managed Medicaid account channel focus

• Partnered with Account Management and Branded Business Units to achieve organizational goals by maximizing managed care opportunities in New England market
• Collaborated with regional and national account managers, brand team, payer marketing and sales managers to identify, develop, execute, and measure local and national market pull-through programs
• 1 of 7 Market Access Managers responsible for covering entire US
• Identified, developed, and executed 2 National Pull-Through Initiatives: CNS & Respiratory
• Identified, developed, and executed multiple regional level pull-through initiatives
• Executed field rides with sales personnel as well as providing analytical support for five business units towards maximizing pull-through
• Teva lead for regional IDNs/Provider Networks (Reliant, Atrius, Partners, NEQCA & Signature Healthcare
• Teva Respiratory